Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Targeting ligand-drug conjugate having cell endocytosis mediating function

A technology targeting ligands and conjugates, applied in the field of biomedical chemistry, can solve the problems of animal poisoning death, low curative effect, high toxicity, etc., and achieve the effects of enhancing drug efficacy, reducing drug toxicity, and ensuring stability

Active Publication Date: 2017-03-01
COHERENT BIOPHARMA (SUZHOU) LTD
View PDF9 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, when they are coupled with conventional chemotherapeutic drugs (such as doxorubicin, paclitaxel), the curative effect is low, and after coupling with high-efficiency drug molecules (such as MMAE, DM1, etc.), which are commonly used in ADCs, the toxicity is high, and the effective dose for tumor treatment will lead to animal poisoning death

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Targeting ligand-drug conjugate having cell endocytosis mediating function
  • Targeting ligand-drug conjugate having cell endocytosis mediating function
  • Targeting ligand-drug conjugate having cell endocytosis mediating function

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027] The preparation method of the present invention is specifically described below in conjunction with the examples:

[0028] The present invention discloses a targeting ligand-drug conjugate with cell endocytosis mediating function. The drug conjugate includes a drug molecule and a linker coupled to the drug molecule. The drug conjugate The body also includes molecules with endocytosis mediation and ligands that specifically bind to cell surface receptors. The ligands can be polypeptides or small molecule ligands, but there are also some special ligands that also have endocytosis. Function and target receptor binding function (such as folic acid, P11, P12 polypeptides). The endocytosis mediating molecule and the ligand can be coupled with each other, then coupled with a drug molecule or a linker to form a drug conjugate, or separately coupled with one of the drug molecule and the linker to form a drug conjugate.

[0029] Wherein, the molecule with endocytosis mediating e...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a targeting ligand-drug conjugate having a cell endocytosis mediating function. The targeting ligand-drug conjugate comprises a drug molecule and a linker coupled to the drug molecule, and is characterized by further comprising a molecule having a mediating effect and a ligand specifically bound to a cell surface receptor, wherein the ligand is a polypeptide or small molecule ligand, and the molecule can be coupled to the ligand, can be coupled to the drug molecule or linker to form the drug conjugate, or is respectively and separately coupled to one of the drug molecule and the linker to form the drug conjugate. According to the present invention, with the combination of the targeting and the endocytosis (transmembrane) structure, the any ligand targeting polypeptide can be adopted as the leader so as to broaden the targeting range of the drug; and with the conjugate, the stability of the drug during the in vivo circulation is ensured, and the drug toxicity is reduced.

Description

technical field [0001] The invention relates to a drug conjugate, in particular to a targeting ligand-drug conjugate with a cell endocytosis mediating function, and belongs to the field of biomedical chemistry. Background technique [0002] Usually, the pathological and physiological characteristics of diseased cells are significantly different from those of normal cells, one of which is the specific or overexpressed substances (such as: antigens, chemical signals, receptors, etc.) on the surface of diseased cells. No expression or low expression. Antibody-drug conjugates (ADCs) and polypeptide-drug conjugates (PDCs) treat diseases based on this principle. Although some drugs have been marketed or entered clinical research, due to the principle of drug design, ADC and PDC drugs have great limitations in clinical application. [0003] ADC is currently mainly used in the field of tumor therapy. The targeting antibody used has a very high affinity for tumor cell surface anti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/69A61K31/537A61P35/00A61P35/02A61P37/02A61P9/00
Inventor 黄保华戴建王中波谢雪原刘小栋胡新礼
Owner COHERENT BIOPHARMA (SUZHOU) LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products